Twenty-year follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia.

Bone Marrow Transplantation/adverse effects Cyclosporine/therapeutic use Drug Therapy, Combination Follow-Up Studies Graft vs Host Disease/drug therapy,mortality,prevention & control Histocompatibility Testing Humans Leukemia/complications,therapy Methotrexate/therapeutic use Premedication Prevalence Survival Analysis

Cyclosporine Methotrexate